Efficiency of 5-aminolevulinic acid for amnestic mild cognitive impairment and early Alzheimer disease. Confirmatory randomized controlled trial
Not Applicable
Recruiting
- Conditions
- Amnestic mild cognitive impairment and early Alzheimer disease
- Registration Number
- JPRN-UMIN000024911
- Lead Sponsor
- agoya City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)Severe BPSD(behavioral and psychological symptom of dementia) 2)Severe auditory disorder 3)Poor general condition 4)Complication of adequate pharmaceutical management by patients or caregiver 5)Patients with contraindication of MRI (Magnetic resonance imaging) 6)Patients who cannot join this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The alteration of MMSE (mini mental state examination) and CDR (clinical dementia rating Japan)
- Secondary Outcome Measures
Name Time Method The alteration of WMS-R (Wecheler Memory Scale -reviced)logical memory II and ADAS-Jcog (Alzheimer disease assessment scale-Japan)